Initial clinical trial and pharmacokinetics of ThymitaqTM (AG337) by 10-day continuous infusion in patients with advanced solid tumors
Patrick J. Creaven, Lakshmi Pendyala, Neal J. Meropol, Neil J. Clendeninn, Ellen Y. Wu, Gregory M. Loewen, April Proefrock, Amanda Johnston, Mary DixonVolume:
41
Langue:
english
Pages:
4
DOI:
10.1007/s002800050724
Date:
November, 1997
Fichier:
PDF, 135 KB
english, 1997